Advertisement

Pharmacologic Pupil Testing and Imaging for Horner Syndrome

  • Randy Kardon
  • Fion BremnerEmail author
Chapter

Abstract

Anisocoria greater in the dark than in the light suggests an oculosympathetic lesion in the smaller pupil due to poor dilation. The presence of an ipsilateral mild ptosis (Mueller muscle) and/or upside down ptosis and a miotic pupil with impaired dilation (dilation lag) suggests a Horner syndrome. The three neuron, oculosympathetic pathway originates in the hypothalamus and descends in the brainstem and spinal cord (first order) then ascends over the apex of the lung in to the sympathetic chain (second order) to synapse in the superior cervical ganglion. The third order neuron travels with the internal carotid artery to the cavernous sinus where it accompanies cranial nerve VI (short course) and then V1 to enter the orbit. Pharmacologic testing (e.g., topical apraclonidine, cocaine) can establish a diagnosis of a Horner syndrome. Imaging studies of the entire oculosympathetic pathway can be diagnostic for potentially life threatening etiologies.

Keywords

Anisocoria Horner syndrome Dilation lag 

References

  1. 1.
    Bremner FD, Smith SE. Pupil abnormalities in selected autonomic neuropathies. J Neuroophthalmol. 2006;26:19.CrossRefGoogle Scholar
  2. 2.
    Mughal M, Longmuir R. Current pharmacologic testing for Horner syndrome. Curr Neurol Neurosci Rep. 2009;9:9.CrossRefGoogle Scholar
  3. 3.
    Freedman KA, Brown SM. Topical apraclonidine in the diagnosis of suspected Horner syndrome. J Neuroophthalmol. 2005;25(2):5.CrossRefGoogle Scholar
  4. 4.
    Mahoney NR, Liu GT, Menacker SJ, Wilson MC, Hogarty MD, Maris JM. Pediatric Horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions. Am J Ophthalmol. 2006;142:9.CrossRefGoogle Scholar
  5. 5.
    Reede DL, Garcon E, Kardon R, et al. Horner’s syndrome: clinical and radiographic evaluation. Neuroimaging Clin N Am. 2008;18(2):85.CrossRefGoogle Scholar
  6. 6.
    Digre KB, Smoker WR, Yuh WT, et al. Selective MR imaging approach for evaluation of patients with Horner’s syndrome. AJNR Am J Neuroradiol. 1992;13(1):7.Google Scholar
  7. 7.
    Davagnanam I, Fraser CL, Plant GT, et al. Adult Horner’s syndrome: a combined clinical, pharmacological, and imaging algorithm. Eye (Lond). 2013;27(3):8.CrossRefGoogle Scholar
  8. 8.
    Beebe JD, Kardon RH, Thurtell MJ. The yield of diagnostic imaging in patients with isolated Horner syndrome. Neurol Clin. 2017;35(1):145–15.CrossRefGoogle Scholar
  9. 9.
    Almog Y, Gepstein R, Kesler A. Diagnostic value of imaging in Horner syndrome in adults. J Neuroophthalmol. 2010;30(1):11.CrossRefGoogle Scholar
  10. 10.
    Mollan S, Lee S, Senthin L, et al. Comment on adult Horner’s syndrome: a combined clinical, pharmacological, and imaging algorithm [Letter]. Eye. 2013;27:4.CrossRefGoogle Scholar
  11. 11.
    Chen Y, Morgan ML, Barros Palau AE, et al. Evaluation and neuroimaging of the Horner syndrome. Can J Ophthalmol. 2015;50(2):11.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.University of Iowa and Veterans Affairs HospitalIowa CityUSA
  2. 2.National Hospital for Neurology and NeurosurgeryQueen SquareLondonUK

Personalised recommendations